<body><script type="text/javascript"> function setAttributeOnload(object, attribute, val) { if(window.addEventListener) { window.addEventListener('load', function(){ object[attribute] = val; }, false); } else { window.attachEvent('onload', function(){ object[attribute] = val; }); } } </script> <div id="navbar-iframe-container"></div> <script type="text/javascript" src="https://apis.google.com/js/platform.js"></script> <script type="text/javascript"> gapi.load("gapi.iframes:gapi.iframes.style.bubble", function() { if (gapi.iframes && gapi.iframes.getContext) { gapi.iframes.getContext().openChild({ url: 'https://www.blogger.com/navbar/5621345630369022014?origin\x3dhttp://cderwn.blogspot.com', where: document.getElementById("navbar-iframe-container"), id: "navbar-iframe" }); } }); </script>

Drug Evaluation & Research

CDERNEW-TEXT 8/22/2007


Wednesday, August 22, 2007

August 22, 2007

FDA approves Risperdal (risperidone) for two psychiatric conditions in
children and adolescents. FDA News
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01686.html


New and Generic Drug Approvals
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm

ALOCRIL (nedocromil sodium) Ophthalmic Solution, Allergan Inc., Labeling
Revision

Avandamet (rosiglitazone maleate and metformin hydrochloride) Tablets,
SB Pharmco, Labeling Revision

Avandaryl (rosiglitazone maleate and glimepiride) Tablets, SB Pharmco,
Labeling Revision

Escitalopram Oxalate Tablets, Invagen Pharma, Tentative Approval

Phentermine Hydrochloride Tablets, Caraco Pharma, Approval

------------------------------------------------
To subscribe or to unsubscribe from CDERNEW-TEXT

http://list.nih.gov/archives/cdernew-text.html
------------------------------------------------

posted by Mags @ 5:13 PM,




0 Comments:

Post a Comment

<< Home